CLOVIS ONCOLOGY INC (CLVS)

US1894641000 - Common Stock

0.0812 0 (-5.58%)

After market: 0.078 0 (-3.94%)

Buy % Consensus

ChartMill assigns a Buy % Consensus number of 43% to CLVS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.04. This target is 2412.32% above the current price.

CLVS was analyzed by 7 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CLVS.

In the previous month the buy percentage consensus was at a similar level.

CLVS was analyzed by 7 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

0.08

2.02

2.04

2.10

2,387.68%

2,412.32%

2,486.21%

Up and Down Grades

Date	Firm	Action	Rating
2022-11-10	JP Morgan	Downgrade	Neutral -> Underweight
2022-05-06	HC Wainwright & Co.	Downgrade	Buy -> Neutral
2022-05-05	HC Wainwright & Co.	Maintains	Buy
2021-09-21	HC Wainwright & Co.	Maintains	Buy
2021-08-05	HC Wainwright & Co.	Maintains	Buy
2021-05-05	HC Wainwright & Co.	Maintains	Buy